Nationwide Research on the Rewilding of Kindergarten Yards

NCT06390878 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2024-06-24

No results posted yet for this study

Summary

Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities that is associated with altered commensal microbiota and a rising burden of immunological disorders among urban children.

The investigators will estimate how rewilding of kindergarten yards affects commensal microbiome, prevalence of allergies, asthma, atopic dermatitis and infections, cortisol levels, cognitive skills and plasma cytokine levels of children.

Our specific aims are:

To assess if rewilding diversifies health-associated skin, saliva and gut microbiota and reduces infectious diseases and atopic or allergic symptoms.

Assess whether the rewilding has positive effects on cognitive skills. Assess whether the rewilding changes cortisol and plasma cytokine levels. The investigators will recruit altogether 320 (160 per treatment) study subjects aged between 1-5 to questionnaire study (Task 2), from which 120 study subjects will be analyzed more detailed using microbiological and blood samples (Task 1).

Conditions

  • Microbial Colonization
  • Atopic Dermatitis
  • Asthma in Children
  • Allergy
  • Cognitive Change
  • Respiratory Infection
  • Nature, Human

Interventions

OTHER

Biodiversity

In rewilding kindergartens, the yards are modified with biological elements, i.e., vegetation and plantation will be added to the yards.

OTHER

Playground equipment

Playground equipment that increase the physical activity of children will be added to the kindergarten yards.

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER
  • Natural Resources Institute Finland

    lead OTHER_GOV

Principal Investigators

  • Aki Sinkkonen · Natural Resources Institute Finland

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2027-08-30
Completion
2027-08-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06390878 on ClinicalTrials.gov